ellaOne
ulipristal acetate
Contraception, Postcoital
Date of authorisation:
Revision: 31
Last updated:
MedicineHumanAuthorised
Esmya
ulipristal
Leiomyoma
Date of authorisation:
Revision: 16
Last updated:
MedicineHumanAuthorised
Esmya - referral
ulipristal acetate
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Emergency contraceptives - referral
levonorgestrel
ulipristal acetate
Article 31 referrals
Associated names:
Norlevo
Levonelle/Postinor and Levodonna
ellaOne
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
P/198/2011 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/198/2011
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Ulipristal acetate - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/215/2009
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman